D
Guardant Health, Inc. GH
$44.59 -$1.58-3.42% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -4.98% 14.28% -3.02% -4.99% 10.75%
Total Depreciation and Amortization -1.90% -2.09% -1.36% -0.24% -0.83%
Total Amortization of Deferred Charges -- -- 0.16% -- --
Total Other Non-Cash Items 9.31% 19.22% -33.70% 11.51% -21.81%
Change in Net Operating Assets 13.27% -724.08% 76.78% 77.28% -782.57%
Cash from Operations 3.83% 2.83% -26.35% 45.68% -210.40%
Capital Expenditure -26.69% 76.38% -349.51% 17.29% 26.78%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -101.63% 945.14% 110.12% -- -100.00%
Cash from Investing -103.52% 2,776.20% 103.57% -5,707.11% -118.09%
Total Debt Issued -200.00% -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,102.73% -84.73% 25,045.00% -99.79% 4,395.77%
Repurchase of Common Stock 87.74% -654.17% -179.16% 11.30% -109.84%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 139.85% -20,677.97% 290.32% 92.92% -270.43%
Cash from Financing 102.43% -2,177.68% -1.73% -148.91% 649.16%
Foreign Exchange rate Adjustments 21.22% 145.60% -189.21% 327.00% 26.45%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -139.27% 397.03% 83.10% -268.94% -2,022.30%